Clinical Trial: Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Irbesartan Versus Placebo in Combination With Standard Cardiovascular Protection ACE-I Therapy With Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at E

Brief Summary: Albumin in the urine is usually a signal that you might be at risk of cardiovascular complications. The purpose of this study is to determine if the albumin in your urine can be decreased by the treatment regimen that consists of irbesartan taken at the same time with ramipril.

Detailed Summary:
Sponsor: Bristol-Myers Squibb

Current Primary Outcome: Change in AER from baseline to Week 20

Original Primary Outcome:

Current Secondary Outcome: Change from baseline in seated systolic and diastolic blood pressures at Week 20; Comparison of change from baseline in seated systolic and diastolic blood pressures at Week 20 between treatment groups

Original Secondary Outcome:

Information By: Bristol-Myers Squibb

Dates:
Date Received: November 2, 2004
Date Started: September 2004
Date Completion:
Last Updated: April 7, 2011
Last Verified: September 2008